chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: This initial spontaneous case, was received on 13-Oct-2017, from a pharmacist, concerning a 70-year-old female patient. The patient's medical history and concomitant medications were not reported. On 27-Sep-2017, the patient received FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular: anatomical location: left deltoid, batch number: 178623 (as reported) and expiry date: Apr-2018). On 28-Sep-2017, the patient had dark redness (3 inches in diameter) and warmth around injection site. It was reported that, the patient did not receive any medications as a treatment. On an unspecified date (reported as within 2-5 days), the patient had recovered from the events. The reporter considered this case as non-serious. Follow-up received on 23-Oct-2017: The event outcome was changed from not reported to recovered (within 2-5 days). Narrative amended accordingly.
Age: 26.0
Sex: F
Vaccine: FLUA3
Symptoms: Drug administered to patient of inappropriate age, No adverse event, Wrong drug administered
Clinical narrative: This initial spontaneous case, received on 05-Oct-2017, was reported by a pharmacist and concerns 26-year-old female patient. Patient's medical history and concomitant medications were not reported. On 04-Oct-2017, the patient received FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 179002 expiry date: May-2018). On 04-Oct-2017, 26-year-old female received FLUAD vaccine (explicitly coded as inappropriate age at vaccine administration) instead of the FLUCELVAX. It was reported that, the patient had no adverse events since vaccine administration. The reporter assessed this case non-serious. Follow-up received on 16-Oct-2017: The vaccine administration details (route of administration: intramuscular, anatomical location: deltoid) were updated. It was reported that the patient had no adverse events since vaccine administration. Narrative amended accordingly. Significant case correction received 05-Oct-2017: The event "wrong vaccine administered" was deleted. The narrative was amended accordingly.
Sex: M
Vaccine: FLUX
Symptoms: Nonspecific reaction
Clinical narrative: This initial non-serious spontaneous case, was received from a pharmacist, concerning a patient of unspecified age and gender. On an unspecified date, the patient received influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). On an unspecified date, the patient experienced unspecified reaction. No further information was available.
Age: 69.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site bruising, Injection site discolouration
Clinical narrative: This spontaneous case, received from pharmacist on 03-Oct-2017, concerning a female patient of unspecified age. On 20-Sep-2017, the patient was vaccinated with FLUAD (dose: 0.5ml, route of administration: intramuscular, anatomical location: left deltoid and Lot no: 178701 and expiry date: unspecified date in April 2018). On an unspecified date, after vaccination, the patient experienced bruise that keeps getting bigger (1 inch) in size at the injection site and it was green in color. Greenness came right away and increasing in size. It was reported that, there was no sore and everything was fine. On an unspecified date, the patient was recovered from the event. As per the reporter, it was "just a little bit green and had resolved". The reporter assessed this case as non-serious. Follow-up received on 11-Oct 2017: Outcome of the events were updated to recovered/ resolved from not recovered. Narrative was amended accordingly. Non-significant case correction received 11-Oct-2017: Narrative was amended with relevant information.
Age: 23.0
Sex: F
Vaccine: FLUA3
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: This initial spontaneous case, was received from pharmacist on 20-Oct-2017, concerning a 23-year-old adult female patient. The patient had no relevant medical history and she did not receive any concomitant medications. On 20-Oct-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 179103, expiry date: May-2018). The patient under 65 years of age received the vaccine (explicitly coded as inappropriate age at vaccine administration). The reporter assessed the event as non-serious.
Sex: M
Vaccine: FLU3, PPV
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Case number PHHY2016US180724, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 648083) website on 21 Dec 201. This report refers to a 54 years old male patient. Past medical history was not reported. Concomitant medications included albuterol inhaler and nicotine gum. The patient was vaccinated with FLUVIRIN (batch number: 174271) in right deltoid (also reported as right arm) along with PNEUMOVAX (Merck & co. Inc, batch number: L018503) in left deltoid (also reported as left arm), both on 01 Feb 2016. On the same day after vaccination, the patient experienced redness, swelling and warm to the touch. The patient was treated with diphenhydramine (1 tab at bedtime). The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 25.0
Sex: F
Vaccine: FLU3, HPV4
Symptoms: Abdominal discomfort, Decreased appetite, Urticaria, Vomiting
Clinical narrative: Case number PHHY2016US181128, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 648642) website on 21 Dec 2016. This report refers to a 25 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1618701) intramuscularly in left arm along with GARDASIL (manufacturer unknown, batch number: L035105) intramuscularly in right arm, both on 10 Aug 2016. On 11 Aug 2016 (reported as next day), the patient experienced hives on arm that spread to back and side of body, upset stomach, loss of appetite and vomiting. On 19 Aug 2016, the patient still had stomach upset and loss of appetite with potential weight loss and the hives went away. The patient visited the emergency room. The final outcome of the events was unknown. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Mobility decreased, Vision blurred
Clinical narrative: Case number PHHY2016US180750, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 649033) website on 21 Dec 2016. This report refers to a 68 years old female patient. Past medical history and concomitant medications were not reported. Current condition included asthma. The patient was vaccinated with FLUVIRIN (batch number: 1618901) intramuscularly in left arm on 21 Aug 2016. On the same day after vaccination, the patient felt dizzy after 45 min of getting the vaccine to the extent she could not move and it got better the following day. She had a little blurry vision but she could drive and work. The patient stated she was still a little dizzy. The final outcome of the events was not reported (reported as missing). The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Contusion
Clinical narrative: Case number PHHY2016US180691, is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS reference number: 649532) on 21 Dec 2016. This report refers to a 62 year old female patient. Medical history included fibromyalgia. Concomitant medications included XANAX 0.5 mg and MOTRIN 200 mg at a dose of 1-2 per oral thrice a day (TID) PRN. The patient was vaccinated with FLUVIRIN (batch number: 1618801) into left arm on 19 Aug 2016. On 20 Aug 2016, the patient developed small bruise (2 cm). The patient fully recovered from the event on an unknown date. The event was reported as non-serious. The causality of the event was not reported.
Age: 35.0
Sex: M
Vaccine: DTAP, FLU3, HEPA
Symptoms: No adverse event, Product storage error
Clinical narrative: Case number PHHY2016US181530, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 649583) website on 21 Dec 2016. This report refers to a 35 years old male patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1619901) intramuscularly in arm on 12 Aug 2016. The patient was also vaccinated VAQTA (Merck and Co. Inc. and batch number: M015773) along with INFANRIX (GlaxoSmithKline Biologicals, batch number: LL2F6), both intramuscularly in arm on 12 Aug 2016. It was reported that, due to refrigerator temperature excursion on 12 Aug 2016, the manufacture determined, based on drop in temperature the vaccine was not viable and recommended revaccination. No adverse event was reported following this administration error.
Age: 31.0
Sex: M
Vaccine: FLU3
Symptoms: Feeling hot, Nodule, Swelling
Clinical narrative: Case number PHHY2016US180730, is an initial spontaneous report received from the Vaccine Adverse Events Reporting System (VAERS reference number: 651679) on 21 Dec 2016. This report refers to a 31 years old male patient. Medical history was not reported. Historical medication included Ibuprofen. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 167804) intramuscularly into left arm on 07 Sep 2016. On 08 Sep 2016 after vaccination, the patient developed golf-ball sized knot, localized heat, swelling. No fever, no limited joint movement and no infection. The patient went to emergency room on and unknown date and received a steroid shot. The outcome of the events was reported as complete recovery. The seriousness of the events was reported as non serious and causality was not reported.
Age: 36.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site pruritus, Injection site swelling
Clinical narrative: Case number PHHY2016US180769, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 651985) on 21 Dec 2016. This report refers to a 36 years old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1619401) intramuscularly on 03 Sep 2016. The patient was also vaccinated with PNEUMOVAX (manufacturer unknown, batch number: L026033) intramuscularly on 03 Sep 2016. On the same day after vaccination, the patient experienced swelling and itching in the left arm at 6 inches below the deltoid area. It was reported that the patient was treated with Ibuprofen 600 mg, ice compress and BENADRYL since 03 Sep 2016. Upon follow up from the patient on 07 Sep 2016, it was reported that the patient was getting better. The seriousness of the events was reported as non-serious and causality was not reported.
Age: 55.0
Sex: M
Vaccine: FLU3
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Case number PHHY2016US181794, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 654135) on 21 Dec 2016. This report refers to a 55 years old male patient. Medical history and concomitant medication was not reported. The patient was mistakenly vaccinated with FLUVIRIN (batch number: not reported) on 17 Sep 2016 instead of FLUARIX QUADRIVALENT ((other manufacturer), batch number: not reported). It was reported that, it was going to be reprocessed with the correct vaccine. No adverse event was reported following the maladministration. The seriousness of the event was reported as non serious.
Age: 50.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Peripheral swelling, Pruritus, Rash
Clinical narrative: Case number PHHY2016US181844, is an initial spontaneous report received from a health care professional via Vaccine Adverse Event Reporting System website (654389) on 21 Dec 2016. This report refers to a 50-year-old female patient. Medical history was not reported. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 162041) into left arm intramuscular and ZOSTAVAX (lot number: M026874) into left arm subcutaneous on 16 Sep 2016. On 17 Sep 2016 the patient experienced rash, swelling, and itching throughout her entire arm. Outcome of the event was complete recovery. Seriousness of the events was reported as non serious and causality was not reported.
Age: 51.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Influenza like illness
Clinical narrative: Case number PHHY2016US181545, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 655188) website on 21 Dec 2016. This report refers to a 51 years old male patient. Past medical history was not reported. Current conditions included as chronic obstructive pulmonary disease (COPD) and smoking use. Concomitant medications was not reported. The patient was vaccinated with first dose of FLUVIRIN (batch number: 168804) into left leg, intramuscularly on 17 Sep 2016. The patient also vaccinated with PNEUMOVAX vaccine (other manufacturer and batch number: M027552) into left arm, intramuscularly on 17 Sep 2016. On the same day after vaccination, the patient experienced severe flu like symptoms into 02 days that resolved with over the counter (OTC) ibuprofen use. The outcome of the event was reported as complete recovery on an unknown date. The seriousness and causality of the event were not reported.
Age: 58.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Middle insomnia, Pain in extremity, Pruritus, Skin warm
Clinical narrative: Case number PHHY2016US181448, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 655345) on 21 Dec 2016. This report refers to a 58 years old female patient. Historical condition was not reported. Current condition included asthma. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: not reported) and ZOSTAVAX (other manufacturer), batch number: not reported) on 21 Sep 2016. On 22 Sep 2016 after vaccination, the patient woke up in middle of night with arm itching, she scratched it sore and hot (3 inches long, 1 inch wide area) on right side on back of arm. The patient was recommended cold compress, hydrocortisone cream, BENADRYL or ZYRTEC. The outcome of the events was reported as unknown. The seriousness of the events was reported as non serious and causality was not reported.
Age: 57.0
Sex: M
Vaccine: FLU3
Symptoms: Chest pain, Injection site pain, Pain in extremity
Clinical narrative: Case number PHHY2016US181791 is initial spontaneous report received from other health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 655375) website on 21 Dec 2016. This report refers to 57 year old male patient. Medical history included GERD (gastroesophageal reflux disease) and possible seasonal allergies. The patient had no known specific illness. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 1619401) intramuscular into left arm on 21 Sep 2016. On same day, patient returned to inform use he had non-specific pain from the wrist up around his shoulder and to his chest in the same arm in which he received his flu shot. His left arm to be specific unsure of specifics, but patient presented to ER (emergency room/doctor) to be checked out. No diagnoses were given and aware of patient seems to be fine. The outcome of the events was complete recovery. The seriousness and causality of the events was not reported.
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Blood glucose abnormal, Blood pressure decreased, Dizziness
Clinical narrative: Case number PHHY2016US181734, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 655532) on 21 Dec 2016. This report refers to a 63 years old female patient. Medical history was not reported. Concomitant mediation included B complex injection. The patient was vaccinated with FLUVIRIN (batch number: 1619601) intramuscularly in to left arm and on 23 Sep 2016. On the same day after vaccination, the patient felt dizzy and she was given fluids and some source of carbohydrates but the patient still felt dizzy, so the patient was taken to the urgent care nearby. At the urgent care, the patient's blood pressure was checked which was 97/86 (units unspecified) and gave her some juice, afterward checked her blood sugar and it was 103 (units unspecified). The patient feet was elevated and she was laid down for 30-45 minutes and then checked her blood pressure, it was 110/80 (units unspecified) and the patient started to feel normal. The outcome of the events was reported as complete recovery. The seriousness of the events was reported as non serious and causality was not reported.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Vaccination site irritation
Clinical narrative: Case number PHHY2016US181986, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 656086) on 21 Dec 2016. This report refers to a 33 years old female patient. Medical history was not reported. The patient had no known allergies. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 1619901) intramuscularly into left arm on 27 Sep 2016. On same day after vaccination, the patient experienced local irritation to vaccination site, mild redness which was visible. The patient was treated with BENADRYL GEL, it was applies topically. It was reported that, the redness diminished within 15 minutes and no further treatment required. The patient followed up the next day and no further reaction noted and reported to work. The outcome of the events was reported as complete recovery. The seriousness of the events was reported as non serious and causality was not reported.
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site irritation
Clinical narrative: Case number PHHY2016US182026, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 656088) website on 21 Dec 2016. This report refers to a 41 years old female patient. Past medical history was not reported. Current condition included as hypertension. Concomitant medications was not reported. The patient was vaccinated with FLUVIRIN (batch number: 1619901) into right arm, intramuscularly on 27 Sep 2016. On the same day after vaccination, the patient had local irritation to injection site, mild redness visible with no complaints of itchiness. The patient received BENADRYL gel applied topically. Patient released at 02:10 pm with decreased redness. No further treatment required. Follow up next day rash had vanished within one hour post injection as per patient. The patient reported to work. The outcome of the events was reported as complete recovery on an unknown date. The seriousness and causality of the events were not reported.
Age: 54.0
Sex: F
Vaccine: FLU3, PPV, TDAP
Symptoms: Influenza like illness, Injection site erythema, Injection site pustule, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2016US182262, is an initial spontaneous report received from a health care professional via vaccine adverse event reporting system website (VAERS: 656394) on 21 Dec 2016. This report refers to a 54-year-old female patient. Historical condition included topical hives (Due to Latex). Current conditions included allergy to latex (caused topical hives), allergy to penicillin and drug allergy. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: not reported) into left arm intramuscularly and PNEUMOVAX (lot number: M020521) into left arm intramuscularly and BOOSTRIX (lot number: AH4LF) into right arm intramuscularly on 22 Sep 2016 around 12 pm. The patient experienced flu-like symptoms, fever, and the injection site in left arm became very hot, red, and swollen on the evening of 23 Sep 2016. The injection site formed two pus-filled heads and may need to be lanced. The patient went to the clinic and was prescribed cephalexin, prednisone, and benzonatate. The patient contacted and spoke with reporter on 29 Sep 2016 and stated that she was doing better. Outcome of the events was condition improving. Seriousness of the events was reported as non serious and causality was not reported.
Age: 54.0
Sex: F
Vaccine: FLU3, PPV, TDAP
Symptoms: Pyrexia
Clinical narrative: Case number PHHY2016US182262, is an initial spontaneous report received from a health care professional via vaccine adverse event reporting system website (VAERS: 656394) on 21 Dec 2016. This report refers to a 54-year-old female patient. Historical condition included topical hives (Due to Latex). Current conditions included allergy to latex (caused topical hives), allergy to penicillin and drug allergy. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: not reported) into left arm intramuscularly and PNEUMOVAX (lot number: M020521) into left arm intramuscularly and BOOSTRIX (lot number: AH4LF) into right arm intramuscularly on 22 Sep 2016 around 12 pm. The patient experienced flu-like symptoms, fever, and the injection site in left arm became very hot, red, and swollen on the evening of 23 Sep 2016. The injection site formed two pus-filled heads and may need to be lanced. The patient went to the clinic and was prescribed cephalexin, prednisone, and benzonatate. The patient contacted and spoke with reporter on 29 Sep 2016 and stated that she was doing better. Outcome of the events was condition improving. Seriousness of the events was reported as non serious and causality was not reported.
Age: 58.0
Sex: M
Vaccine: FLU3
Symptoms: Musculoskeletal stiffness, Neck pain
Clinical narrative: Case number PHHY2016US181747 is initial spontaneous report received from other health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 657334) website on 21 Dec 2016. This report refers to 58 year old male patient. Medical history and concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 168705) intramuscular into right arm on 30 Sep 2016. On 01 Oct 216 the patient experienced stiff and sore neck. The outcome of the events was unknown. The seriousness of the events was not reported. The causality of the events was not reported.
Sex: F
Vaccine: FLU3, PPV
Symptoms: Chills, Hypoaesthesia, Injected limb mobility decreased, Injection site pain, Pyrexia
Clinical narrative: Case number PHHY2016US181470, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 657556) on 21 Dec 2016. This report refers to a 55 years old female patient. Historic condition included fibromyalgia. Current condition not reported. Concomitant medication included carisoprodol 350 mg and estradiol 1 mg. The patient was vaccinated with FLUVIRIN (seasonal, batch number: 168605) into right arm and PNEUMOVAX (manufacturer unknown, batch number: M018766) into left arm intramuscularly on 01 Oct 2016. After vaccination, on 02 Sep 2016 the patient experienced tenderness at local sight, radiating pain down back of arm to elbow, numbness in fingers and was only able to lift arm one third of the way up, fever and chills. It was reported that patient was taking ibuprofen to alleviate symptoms (all symptoms of left arm) and using heating pad. The outcome of the events was reported as unknown. The seriousness of the events was reported as non-serious and causality was not reported.
Age: 37.0
Sex: F
Vaccine: FLU3
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Case number PHHY2016US181754, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 657736) on 21 Dec 2016. This report refers to a 37 years old female patient. Medical history was not reported. Concomitant medication included SYNTHROID. The patient was vaccinated with FLUVIRIN (batch number: not reported) into right arm intramuscularly on 05 Oct 2016. On the same day after vaccination, the patient experienced tingling and numbness in right arm (same arm where the shot was administered) all the way down the arm to the hand, mainly on pinky and ring finger. It was reported that the symptoms lasted approximately for 12 hours. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non-serious and causality was not reported. The Quality Assurance department confirmed that the initially reported batch number 16196D was not valid for FLUVIRIN.
Age: 70.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site bruising
Clinical narrative: Case number PHHY2016US182032, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS, reference number: 657949) on 21 Dec 2016. This report refers to a 70 years old female patient. Past medical history was not reported. Current condition included asthma. Concomitant medications included Aspirin and nabumetone. She was vaccinated with FLUVIRIN (lot number: 1618901) intramuscularly into the right arm on 16 Aug 2016. After vaccination, on 17 Aug 2016, large, dark bruise at injection site which was still there after 40 days. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
Sex: F
Vaccine: FLU3
Symptoms: Immediate post-injection reaction, Injection site bruising, Injection site haemorrhage, Injection site induration, Injection site mass
Clinical narrative: Case number PHHY2016US182040, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 657950) website on 21 Dec 2016. This report refers to a 45 years old female patient. Medical history and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 169005) intramuscularly into right arm on 05 Oct 2016. On the same day after vaccination, the patient was bleeding when the needle was taken out. It was reported that, the patient developed a large hard lump immediately after vaccination and the patient had applied ice to site. It was reported that, later in a day, the patient developed a red raised rash all around the site. The patient took BENADRYL. It was reported that the large dark bruise remained and the rash had resolved. The outcome of the event vaccination site bruise was reported as condition unchanged and for other events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non-serious and causality was not reported.
Sex: F
Vaccine: FLU3
Symptoms: Injection site reaction, Rash erythematous
Clinical narrative: Case number PHHY2016US182040, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 657950) website on 21 Dec 2016. This report refers to a 45 years old female patient. Medical history and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 169005) intramuscularly into right arm on 05 Oct 2016. On the same day after vaccination, the patient was bleeding when the needle was taken out. It was reported that, the patient developed a large hard lump immediately after vaccination and the patient had applied ice to site. It was reported that, later in a day, the patient developed a red raised rash all around the site. The patient took BENADRYL. It was reported that the large dark bruise remained and the rash had resolved. The outcome of the event vaccination site bruise was reported as condition unchanged and for other events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non-serious and causality was not reported.
Age: 54.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Muscular weakness, Musculoskeletal pain, Myalgia, Pain, Pain in extremity
Clinical narrative: Case number PHHY2016US180819, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 658167) on 21 Dec 2016. This report refers to a 54 years old female patient. Historical condition included migraines. Current condition included rheumatoid arthritis. Concomitant medications included prednisone, methotrexate, Hydroxychloroquine and NEXIUM. The patient was vaccinated with FLUVIRIN (batch number: 1618901) and PNEUMOVAX (batch number: L033707) on 06 Oct 2016. On 07 Oct 2016 after vaccination, the patient experienced fever with body temperature 100.2, generalized body aches/localized body aches, vomiting, pain and weakness in right shoulder/arm, deltoid. The patient was recommended TYLENOL and bed rest. The patient was seen at urgent care. The outcome of the events was reported as unknown. The seriousness of the events was reported as non serious and causality was not reported.
Age: 54.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Pyrexia, Vomiting
Clinical narrative: Case number PHHY2016US180819, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 658167) on 21 Dec 2016. This report refers to a 54 years old female patient. Historical condition included migraines. Current condition included rheumatoid arthritis. Concomitant medications included prednisone, methotrexate, Hydroxychloroquine and NEXIUM. The patient was vaccinated with FLUVIRIN (batch number: 1618901) and PNEUMOVAX (batch number: L033707) on 06 Oct 2016. On 07 Oct 2016 after vaccination, the patient experienced fever with body temperature 100.2, generalized body aches/localized body aches, vomiting, pain and weakness in right shoulder/arm, deltoid. The patient was recommended TYLENOL and bed rest. The patient was seen at urgent care. The outcome of the events was reported as unknown. The seriousness of the events was reported as non serious and causality was not reported.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Injection site reaction, Injection site warmth, Muscle tightness
Clinical narrative: Case number PHHY2016US182322, is an initial spontaneous report received from a health care professional via vaccine adverse event reporting system (VAERS: 658174) website on 21 Dec 2016. This report refers to a 52-year-old female patient. Historical condition was not reported. Concomitant medication was not reported. The patient received 1 dose of FLUVIRIN (lot number: 1618701) intramuscular on 07 Oct 2016. On the same day of vaccination the patient experienced very sore arm, below injection site, around muscle and tightness and throbbing. The patient was treated with ibuprofen and ice, no welt on injection but warmness. Outcome of the events was unknown. Seriousness of the event was reported as non serious and causality was not reported.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Drug administered at inappropriate site, Injected limb mobility decreased, Myalgia, Pain
Clinical narrative: Case number PHHY2016US181181, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 168723) website on 21 Dec 2016. This report refers to a 45-years-old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 168723) intramuscularly in left arm on 27 Sep 2016. On the same day after vaccination the patient experienced muscle pain extremely and could not still raise her left arm and it was hurt to lift it up. The physician believed that the vaccine was injected too high in deltoid (into bursa sac). The outcome of events is reported as condition unchanged. The seriousness and causality of the events were not reported.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Limb discomfort, Musculoskeletal stiffness, Pain, Pain in extremity
Clinical narrative: Case number PHHY2016US181984, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 658239) on 21 Dec 2016. This report refers to a 46 years old female patient. Medical history was not reported. Concomitant medication was reported as unknown. The patient was vaccinated with FLUVIRIN (batch number: 168723) intramuscularly into right arm on 27 Sep 2016. On same day after vaccination, the patient experienced soreness and discomfort when raising her arm over shoulder level, even after over a week later, discomfort when steering car, stiffness and pain extends past her elbow. The outcome of the events was reported as unknown. The seriousness of the events was report as non serious and causality was not reported.
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Contusion, Drug administered at inappropriate site, Pain in extremity
Clinical narrative: Case number PHHY2016US181837, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 658242) website on 21 Dec 2016. This report refers to a 26 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 168723) into right arm, intramuscularly on 27 Sep 2016. On the same day after vaccination, the patient experienced arm very sore for about a week and bruise for about a week. It was reported that, vaccination location too high in Deltoid. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
Age: 38.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pain
Clinical narrative: Case number PHHY2016US182023, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 658243) on 21 Dec 2016. This report refers to a 38 years old female patient. Medical history was not reported. Concomitant medication was reported as unknown. The patient was vaccinated with FLUVIRIN (batch number: 168723) intramuscularly into right arm on 27 Sep 2016. On same day after vaccination, the patient experienced sore/tenderness at site, red and swollen, very sore and discomfort when lift arm. The outcome of the events was reported as unknown. The seriousness of the events was reported as non serious causality was not reported.
Age: 38.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Injection site joint pain, Injection site pain
Clinical narrative: Case number PHHY2016US182023, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 658243) on 21 Dec 2016. This report refers to a 38 years old female patient. Medical history was not reported. Concomitant medication was reported as unknown. The patient was vaccinated with FLUVIRIN (batch number: 168723) intramuscularly into right arm on 27 Sep 2016. On same day after vaccination, the patient experienced sore/tenderness at site, red and swollen, very sore and discomfort when lift arm. The outcome of the events was reported as unknown. The seriousness of the events was reported as non serious causality was not reported.
Age: 38.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pain
Clinical narrative: Case number PHHY2016US181983, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 658248) website on 21 Dec 2016. This report refers to a 38 years old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 168723) intramuscularly into left arm on 27 Sep 2016. On the same day after vaccination, the patient experienced soreness/tenderness constantly in left shoulder. It was reported that, on an unknown date, the pain had woke the patient about 2 to 4 in the morning and it felt more like joint pain. The differential diagnosis showed too superior injection in deltoid (in bursa sac). The outcome of the events was reported as unknown. The seriousness of the events was reported as non-serious and causality was not reported.
Age: 38.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Injection site joint pain, Injection site pain
Clinical narrative: Case number PHHY2016US181983, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 658248) website on 21 Dec 2016. This report refers to a 38 years old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 168723) intramuscularly into left arm on 27 Sep 2016. On the same day after vaccination, the patient experienced soreness/tenderness constantly in left shoulder. It was reported that, on an unknown date, the pain had woke the patient about 2 to 4 in the morning and it felt more like joint pain. The differential diagnosis showed too superior injection in deltoid (in bursa sac). The outcome of the events was reported as unknown. The seriousness of the events was reported as non-serious and causality was not reported.
Age: 31.0
Sex: F
Vaccine: FLU3
Symptoms: Musculoskeletal stiffness, Neck pain
Clinical narrative: Case number PHHY2016US181721, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 658511) website on 21 Dec 2016. This report refers to a 31-years-old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1619221) intramuscularly in right arm on 29 Sep 2016. On 30 Sep 2016 after vaccination, the patient experienced stiffness of neck and neck pain. The outcome of the events was reported as complete recovery on an unspecified date. The seriousness and causality of the events were not reported.
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Vaccination site induration, Vaccination site swelling
Clinical narrative: Case number PHHY2016US181217, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 659253) website on 21 Dec 2016. This report refers to a 26 years old female patient. Past medical history was not reported. Concomitant medications included doxycycline monohydrate, NUVARING, spironolactone, montelukast, hydrocodone/acetaminophen, ACZONE GEL, clindamycin phosphate solution. The patient was vaccinated with FLUVIRIN (batch number: 1619901) intramuscularly into the left arm on 12 Oct 2016. On the same day after vaccination, her vaccination site was raised to a size of a quarter above arm, red, area hard like bee sting, very sore and a little itchy. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 61.0
Sex: M
Vaccine: FLU3, VARZOS
Symptoms: Blood test, Musculoskeletal pain, Pain in extremity
Clinical narrative: Case number PHHY2016US180790, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 659603) on 21 Dec 2016. This report refers to a 61 years old male patient. Medical history was not reported. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: NDC70461) and ZOSTAVAX (batch number: NC00006) into arm on an unknown date. After vaccination on an unknown date, the patient developed soreness and pain in arm and shoulder up to 15 days or more. It was believed that, the assistant was inexperience, took 4-5 attempts to get blood test (details unspecified). The outcome of the events was reported as unknown. The seriousness of the events was reported as non serious and causality was not reported.
Age: 27.0
Sex: F
Vaccine: FLU3
Symptoms: Contusion, Cough, Influenza like illness, Pain, Peripheral swelling
Clinical narrative: Case number PHHY2016US181756, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 659607) website on 21 Dec 2016. This report refers to a 27-years-old female patient. Past medical history was not reported. Current conditions included allergy to all nuts except peanuts and MOTRIN allergy. Concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1618621) in right arm at 14:30 on 22 Sep 2016. On 06 Oct 2016 after 02 weeks of vaccination, the patient experienced swollen, bruised arm which was warm to the touch and flu-like symptoms as coughing, runny nose and aches or pains. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
Age: 27.0
Sex: F
Vaccine: FLU3
Symptoms: Rhinorrhoea, Skin warm
Clinical narrative: Case number PHHY2016US181756, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 659607) website on 21 Dec 2016. This report refers to a 27-years-old female patient. Past medical history was not reported. Current conditions included allergy to all nuts except peanuts and MOTRIN allergy. Concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1618621) in right arm at 14:30 on 22 Sep 2016. On 06 Oct 2016 after 02 weeks of vaccination, the patient experienced swollen, bruised arm which was warm to the touch and flu-like symptoms as coughing, runny nose and aches or pains. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
Age: 54.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Injection site bruising, Injection site pain
Clinical narrative: Case number PHHY2017US031704 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 659797) website on 21 Feb 2017. This report refers to a 54 year old female patient. Historical condition was not reported. Past medications included codeine. Current illness was reported none. Concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1618701) intramuscularly into left arm on 06 Oct 2016. The patient was also vaccinated with BOOSTRIX (other manufacturer, batch number: EC9A9) into right arm on 06 Oct 2016. After vaccination on 07 Nov 2016 (reported as started the day after injection), patient developed 2 x 4 inch bruise surrounding the injection site. It was reported that the patient on an unknown date (reported as today) described it as sore. The final outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious and causality was not reported.
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Joint range of motion decreased, Pain in extremity
Clinical narrative: Case number PHHY2017US031365, is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS reference number: 659923) website on 21 Feb 2017. This report refers to a 28 years old female patient. Past medical history was not reported. Concomitant medication included ORSYTHIA. The patient was vaccinated with FLUVIRIN (batch number: 168605) intramuscularly in left arm on 03 Oct 2016. On the same day after vaccination the patient experienced sore arm and difficulty with full range of motion in arm. The outcome of the events was assessed as condition unchanged. The seriousness and causality of the events were not reported.
Age: 62.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Contusion, Injection site discolouration, Injection site erythema, Injection site warmth
Clinical narrative: Case number PHHY2017US032461 is an initial spontaneous report received via Vaccine Adverse Events Reporting System (VAERS reference number: 660121) on 21 Feb 2017. This report refers to a 62 years old female patient. Her medical history was not reported. She had no current conditions. Her concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: 1618501) and PNEUMOVAX (other manufacturer, batch number: L029113); both vaccines administered intramuscularly in the left arm on 06 Oct 2016. On 07 Oct 2016, the patient had bruise on left arm and she experienced red, purple reaction from injection site to elbow which was warm to touch. The events outcome was unknown. The events were reported as non-serious. The causality of the events was not reported.
Age: 20.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injected limb mobility decreased, Insomnia, Pain in extremity
Clinical narrative: Case number PHHY2017US031818, is an initial spontaneous report received from Vaccine Adverse Events Reporting System (VAERS reference number: 660177) on 21 Feb 2017. This report refers to a 20 years old female patient. Medical history was not reported. Concomitant medication included Norethindrone. The patient was vaccinated with FLUVIRIN (batch number: 168704) in left arm and pneumococcal vaccine polyvalent (manufacturer: unknown, batch number: L021367) in right arm on 17 Oct 2016 intramuscularly. On 17 Oct 2016, the patient's right arm became very sore and kept her up overnight and she could not lift it. She began using ice and acetaminophen. As of late Tuesday, she had not sought any treatment. The outcome of the events were not reported. Seriousness of the events were reported as non serious. The causality of the events were not reported.
Age: 59.0
Sex: F
Vaccine: FLU3, PPV, TDAP
Symptoms: Erythema, Injection site erythema, Injection site pain, Injection site warmth, Neck pain
Clinical narrative: Case number PHHY2017US032407 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 660331) website on 21 Feb 2017. This report refers to a 59 year old female patient. Historical condition was not reported. Current condition included cholesterol, thyroid, seizures and migraines and current illness of the patient were reported as none. Concomitant medications included LIPITOR, TEGRETOL, MAXALT and SYNTHROID. The patient was vaccinated with FLUVIRIN (batch number: 1620501) intramuscularly into left arm on 05 Oct 2016. The patient was also vaccinated with PNEUMOVAX (other manufacturer, batch number: L034335) intramuscularly into left arm and also with BOOSTRIX (other manufacturer, batch number: C295R) intramuscularly into right arm on 05 Oct 2016. After vaccination on 06 Oct 2016 (reported as day after shots), patient experienced injection site red, warm to touch, very sore and tender even to front and down arm and upwards through neck. Following the events patient visited emergency room on an unknown date. Patient was treated with oral antibiotics for 7 days as preventative. The final outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious and causality was not reported.